Illustration: Kim Ryu for Endpoints News
April 26, 2023 07:00 AM EDTUpdated April 30, 04:58 AM
Cell/Gene Tx
In Focus

CAR-T re­shaped can­cer treat­ment. Can it change au­toim­mune dis­ease, too?

Amber Tong

More than 15 years ago, Aimee Payne was search­ing for a way to hunt down — and tar­get — the cells be­hind a po­ten­tial­ly life-threat­en­ing con­di­tion that …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Am­gen names Stan­ford ge­neti­cist and biotech founder to CSO post

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

Ky­owa Kirin ac­quires ex-US rights to Ku­ra’s leukemia treat­ment for $330M up­front

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times